Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Subconjunctival Aflibercept Injection for Pseudophakic Cystoid Macular Edema

NCT03396861 is registered in ClinicalTrials.gov with Tufts Medical Center as lead sponsor.

NCT NCT03396861
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03396861 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Subconjunctival Aflibercept Injection for Pseudophakic Cystoid Macular Edema
Lead sponsor
Tufts Medical Center
Phase
Phase 1
Overall status
Terminated
Start date
February 22, 2019
Completion date
January 2, 2020
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

irvine-gass syndrome